APA

Walker A. R., Wang H., Walsh K., Bhatnagar B., Vasu S., Garzon R., Canning R., Geyer S., Wu Y., Devine S. M., Klisovic R., Blum W. & Marcucci G. (20180112). Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. : Leukemia & lymphoma.

Chicago

Walker Alison R, Wang Hongyan, Walsh Katherine, Bhatnagar Bhavana, Vasu Sumithira, Garzon Ramiro, Canning Renee, Geyer Susan, Wu Yue-Zhong, Devine Steven M, Klisovic Rebecca, Blum William and Marcucci Guido. 20180112. Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. : Leukemia & lymphoma.

Harvard

Walker A. R., Wang H., Walsh K., Bhatnagar B., Vasu S., Garzon R., Canning R., Geyer S., Wu Y., Devine S. M., Klisovic R., Blum W. and Marcucci G. (20180112). Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. : Leukemia & lymphoma.

MLA

Walker Alison R, Wang Hongyan, Walsh Katherine, Bhatnagar Bhavana, Vasu Sumithira, Garzon Ramiro, Canning Renee, Geyer Susan, Wu Yue-Zhong, Devine Steven M, Klisovic Rebecca, Blum William and Marcucci Guido. Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia. : Leukemia & lymphoma. 20180112.